--- title: "Specialty Medications, Specialty Challenges: Models to Optimize Outcomes" description: Specialty medications present unique patient support challenges. Learn more about the considerations for service models and providers. image: https://blog.ubc.com/hubfs/EDV%20Blog%20Social%20Image-1.png --- [![UBC](https://blog.ubc.com/hs-fs/hubfs/raw_assets/public/UBC_December2021/images/logo-white.png?width=175&name=logo-white.png "UBC")](https://ubc.com/) - [Home](https://ubc.com/) - Services - [Full-Service Clinical Development](https://ubc.com/global-services/) - [Clinical Trial Management & Late Stage Research](https://ubc.com/global-services/trials-and-research/) - [Decentralized Studies & Virtual Engagement](https://ubc.com/global-services/decentralized/) - [Patient & Physician Services](https://ubc.com/global-services/pps/) - [Pharmacovigilance](https://ubc.com/global-services/pharmacovigilance/) - [Risk Management Plans](https://ubc.com/global-services/risk-management/) - [Risk Evaluation and Mitigation Strategies (REMS)](https://ubc.com/global-services/rems/) - [Registries & Observational Studies](https://ubc.com/global-services/registries/) - [Safety & Epidemiology Consulting](https://ubc.com/global-services/epidemiology/) - [Become a Clinical Trial Investigator](https://ubc.com/global-services/become-an-investigator/) - [Patient Support Services](https://ubc.com/patient-support/) - [Access Services](https://ubc.com/patient-support/access-services/) - [Clinical Education](https://ubc.com/patient-support/clinical-education/) - [Connected Health](https://ubc.com/patient-support/connected-health/) - [In-Home Care Coordination](https://ubc.com/patient-support/care-coordination/) - [In-Workflow Services](https://ubc.com/patient-support/in-workflow-services/) - [Outcomes and Value](https://ubc.com/patient-support/outcomes-and-value/) - [Patient Engagement](https://ubc.com/patient-support/patient-engagement/) - [Real World Evidence](https://ubc.com/real-world-evidence/) - [RWE Consulting Practice](https://ubc.com/real-world-evidence/rwe-consulting/) - [Real World Data](https://ubc.com/real-world-evidence/real-world-data/) - [Mosaic Technology Platform](https://ubc.com/real-world-evidence/mosaic-technology-platform/) - [Automated Analytics Software](https://ubc.com/real-world-evidence/analytics-software/) - [Product Lifecycle Solutions](https://ubc.com/product-lifecycle/) - [Cell & Gene Therapy](https://ubc.com/product-lifecycle/cell-gene/) - [COVID-19](https://ubc.com/product-lifecycle/patient-care/) - [Oncology](https://ubc.com/product-lifecycle/oncology/) - [Nursing](https://ubc.com/product-lifecycle/nursing/) - [Rare Disease](https://ubc.com/product-lifecycle/rare-disease/) - [Technology](https://ubc.com/technology/) - [Automated Analytics Software](https://ubc.com/technology/automated-analytics-software/) - [Connected Health](https://ubc.com/technology/connected-health/) - [Decentralized Studies & Virtual Engagement](https://ubc.com/technology/decentralized-studies-virtual-engagement/) - [Mosaic Technology Platform](https://ubc.com/technology/mosaic-technology-platform/) - [Patient Engagement](https://ubc.com/technology/engage/) - [Think Tank](https://blog.ubc.com/blog) - About - [About UBC](https://ubc.com/about/) - [Awards](https://ubc.com/about/awards/) - [Leadership Team](https://ubc.com/about/leadership/) - [Press Releases](https://ubc.com/about/press/) - [Careers](https://ubc.com/careers/) [SUBMIT RFI/RFP](https://ubc.com/contact/) Menu [![UBC](https://blog.ubc.com/hs-fs/hubfs/raw_assets/public/UBC_December2021/images/logo-white.png?width=175&name=logo-white.png "UBC")](https://ubc.com/) - [Home](https://ubc.com/) - Services - [Full-Service Clinical Development](https://ubc.com/global-services/) - [Clinical Trial Management & Late Stage Research](https://ubc.com/global-services/trials-and-research/) - [Decentralized Studies & Virtual Engagement](https://ubc.com/global-services/decentralized/) - [Patient & Physician Services](https://ubc.com/global-services/pps/) - [Pharmacovigilance](https://ubc.com/global-services/pharmacovigilance/) - [Risk Management Plans](https://ubc.com/global-services/risk-management/) - [Risk Evaluation and Mitigation Strategies (REMS)](https://ubc.com/global-services/rems/) - [Registries & Observational Studies](https://ubc.com/global-services/registries/) - [Safety & Epidemiology Consulting](https://ubc.com/global-services/epidemiology/) - [Become a Clinical Trial Investigator](https://ubc.com/global-services/become-an-investigator/) - [Patient Support Services](https://ubc.com/patient-support/) - [Access Services](https://ubc.com/patient-support/access-services/) - [Clinical Education](https://ubc.com/patient-support/clinical-education/) - [Connected Health](https://ubc.com/patient-support/connected-health/) - [In-Home Care Coordination](https://ubc.com/patient-support/care-coordination/) - [In-Workflow Services](https://ubc.com/patient-support/in-workflow-services/) - [Outcomes and Value](https://ubc.com/patient-support/outcomes-and-value/) - [Patient Engagement](https://ubc.com/patient-support/patient-engagement/) - [Real World Evidence](https://ubc.com/real-world-evidence/) - [RWE Consulting Practice](https://ubc.com/real-world-evidence/rwe-consulting/) - [Real World Data](https://ubc.com/real-world-evidence/real-world-data/) - [Mosaic Technology Platform](https://ubc.com/real-world-evidence/mosaic-technology-platform/) - [Automated Analytics Software](https://ubc.com/real-world-evidence/analytics-software/) - [Product Lifecycle Solutions](https://ubc.com/product-lifecycle/) - [Cell & Gene Therapy](https://ubc.com/product-lifecycle/cell-gene/) - [COVID-19](https://ubc.com/product-lifecycle/patient-care/) - [Oncology](https://ubc.com/product-lifecycle/oncology/) - [Nursing](https://ubc.com/product-lifecycle/nursing/) - [Rare Disease](https://ubc.com/product-lifecycle/rare-disease/) - [Technology](https://ubc.com/technology/) - [Automated Analytics Software](https://ubc.com/technology/automated-analytics-software/) - [Connected Health](https://ubc.com/technology/connected-health/) - [Decentralized Studies & Virtual Engagement](https://ubc.com/technology/decentralized-studies-virtual-engagement/) - [Mosaic Technology Platform](https://ubc.com/technology/mosaic-technology-platform/) - [Patient Engagement](https://ubc.com/technology/engage/) - [Think Tank](https://blog.ubc.com/blog) - About - [About UBC](https://ubc.com/about/) - [Awards](https://ubc.com/about/awards/) - [Leadership Team](https://ubc.com/about/leadership/) - [Press Releases](https://ubc.com/about/press/) - [Careers](https://ubc.com/careers/) - [Submit RFI/RFP](https://ubc.com/contact/) Anesthesiology 1. [Home](https://ubc.com/) 2. [Blog](https://blog.ubc.com/blog) 3. Specialty Medications, Specialty Challenges: Selecting a Services Partner & Creating a Model to Optimize Patient Outcomes # Specialty Medications, Specialty Challenges: Selecting a Services Partner & Creating a Model to Optimize Patient Outcomes *Thursday, March 31, 2022* When it comes to experience with specialty medication support models within the industry, a few know a lot, some know more, most only know what they know, and no one knows everything. The landscape for services partner selection has grown dramatically over the last decade. Partner selection considerations for brand and patient service owners may include current and past experience, provider reputation, provider niche, and the use of consultants. Additionally, internal team and department dynamics come into play – it’s not uncommon for RFP scorecards to be used with large internal teams. This creates a huge amount of reference points for decision markers – some could be based on direct experience, others may be by word-of-mouth. #### **Considerations for Services** When evaluating a potential services partner, it is critical to consider the product profile while keeping in mind the relevant points above. Take into account and carefully consider the prescribing specialty, payer type, patient demographics, benefit type, route of administration, frequency of administration, and more. For example, a self-injectable medication like a weekly or bi-weekly biologic will require patient training and support, as well as adherence reminders. An infused product will require appointment coordination and reminders for the required frequency, e.g. monthly, quarterly, or only twice a year. In addition to how a service provider’s capabilities fit your product and patient, you will need to evaluate how their capabilities fit your desired model.  Will services be fully outsourced, fully internal, or will it be a hybrid of manufacturer and service provider technology and employees? These pieces will all factor into how well-positioned a services provider is for your unique product. Further dynamics compounding selection of a specialty services model may include the following options: - Product/Program Status:  New product launch *or* program transition - Fully Outsourced Model: One-stop-shop *or* integration of best-in-breed service providers - Hybrid: Technology considerations – HUB vs pharma CRM, both systems working together, third party technologies, balancing front-end and back-end FTEs - Field Services: FRM, FRS, CNE, PAS, PAM, NN, etc. Each of these model considerations have pros and cons – all of these require a budget, stakeholder alignment, operational know-how, technology (internal/external), and, most importantly, time to implement (as well as ongoing design iterations, system and FTE support post-program launch). Regarding hybrid and internal models, there have been pushes to bring services in-house and launch systems using third-party IT resources – typically within mature programs. The implementation often takes longer than expected for the first launch and consecutive brands. The struggle with this approach is that “I don’t control the IT team – I have to get in line for an IT change and it’s going to take months.” Another consideration: most manufacturers prefer a SalesForce platform as their IT leaders are most familiar with the SFDC system.  What matters the most is not SFDC or another CRM platform, it’s the people who are building it. Do they have the know-how and understanding of your program and operational needs? #### **Key Takeaways for Service Provider Selection** Every owner of a HUB has aspirations for program objectives and service delivery.  RFPs are deployed to solicit recommendations and information from service providers to identify a good match for services and fit the client with a given model in mind. What is important to gain in the RFP process? Is it therapy experience, is it the number of programs, is it the people running the program, is it the technology, is it reporting, is it scale, is it one-stop-shop, is it budget, is it speed? Hub ownership is not an easy job. It takes extensive knowledge and interpersonal skills to navigate internal and external stakeholders. But the effort to implement a HUB is worth it. It enables patients to get on therapy and their lives are changed. When it comes to experience with specialty medication service models within the industry, ultimately, you only know what you have been exposed to when it comes to service models – each program may offer a different level of service to meet the needs of the unique patient and prescriber audience involved. The stakeholder experience drives the value of the program and that is what makes services unique between providers. At UBC, we put Patients First in every aspect of our Patient Access Services, from consulting and design to execution and operations. Our subject matter experts and operations team are highly experienced with traditional and unique models to drive value for your program and maximize patient outcomes. UBC is leaning forward by combing high-touch with high-tech, [automating](https://ubc.com/patient-support/connected-health/) enrollment and approvals to help patients start therapy quicker, and using a [digital assistant](https://ubc.com/patient-support/patient-engagement/) to customize touchpoints tailored to the patient type and individual patient preference. To talk shop and learn more, go [here](https://www.ubcengage.com/#contact). **About the Author** Ed Vegso is a Senior Director, Business Development at UBC. He is an industry leader with more than 25 years of sales, marketing, access, business development, and design experience launching and operationalizing services for specialty medications. ## Related Articles ## [UBC Partners with Surescripts for In-Workflow Specialty Patient Enrollment](https://blog.ubc.com/blog/ubc-partners-surescripts-specialty-patient-enrollment) Surescripts Specialty Patient Enrollment service will enable UBC to offer in-workflow enrollment to... [Read More](https://blog.ubc.com/blog/ubc-partners-surescripts-specialty-patient-enrollment) ## [Alleviating the Complexities of a Cell & Gene Therapy Program Through Patient Support](https://blog.ubc.com/blog/therapy-program-patient-support) There are individuals that are faced with devastating medical challenges every day. One example is people... [Read More](https://blog.ubc.com/blog/therapy-program-patient-support) ## [Breaking Down Patient Barriers to Therapy Through Mobile Messaging & Virtual Assistants](https://blog.ubc.com/blog/healthcare-virtual-assistants) Current State of Healthcare Technology It’s evident within our healthcare system just how challenging it can... [Read More](https://blog.ubc.com/blog/healthcare-virtual-assistants) ![Footer Logo](https://blog.ubc.com/hs-fs/hubfs/raw_assets/public/UBC_December2021/images/logo-blue.jpg?width=113&name=logo-blue.jpg "Footer Logo") #### Quick Links - Subscribe to Think Tank - [Contact UBC](https://ubc.com/contact) - [Privacy](https://ubc.com/privacy-policy) - [Terms of Use](https://ubc.com/terms-of-use) - [Sitemap](https://ubc.com/sitemap) #### RECENT ARTICLES - [Planning for Diversity in Clinical Trials](https://blog.ubc.com/blog/planning-for-diversity-in-clinical-trials) - [Practical Considerations for Evidence Generation](https://blog.ubc.com/blog/practical-considerations-rwe) - [Supporting Patients and Families Through Case Management](https://blog.ubc.com/blog/supporting-patients-and-families-through-case-management) Copyright © 2017-2026 United BioSource LLC, all rights reserved. UBC®, CLÆRITY®, SæfetyWorks®, ExpressConnect® and UBC Pathways® are trademarks of United BioSource LLC. ![close button](https://blog.ubc.com/hubfs/close.png) ### Subscribe to Think Tank #### Look for more industry-related insight coming soon! Thank you for your interest in UBC’s thought leadership!